GNLX
GENELUX Corp
NASDAQ · Healthcare · Biotechnology · US
$2.53
+0.00%0
Insider buys (3m)
7
Insider sells (3m)
-$194.3K
Net value (3m)
-13.5%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Sep 2, 2026 | Yu Yong · officer: Chief Scientific Officer | Sale | 9,683 | $2.75 |
| Sep 2, 2026 | Zindrick Thomas · officer: President and CEO | Sale | 34,463 | $2.67 |
| Sep 2, 2026 | Cappello Joseph · officer: Chief Technical Officer | Sale | 10,257 | $2.74 |
| Aug 4, 2026 | Cappello Joseph · officer: Chief Technical Officer | Sale | 653 | $2.95 |
| Aug 4, 2026 | Yu Yong · officer: Chief Scientific Officer | Sale | 653 | $2.94 |
| Aug 4, 2026 | Zindrick Thomas · officer: President and CEO | Sale | 3,023 | $2.95 |
| Jul 2, 2026 | Smither John W · director | Sale | 12,000 | $2.91 |
| Jun 18, 2026 | Smither John W · director | A-Award | 31,566 | $3.03 |
| Jun 18, 2026 | Pulisic Matthew · officer: Chief Financial Officer | A-Award | 278,906 | $0.00 |
| Jun 18, 2026 | Groen Eric · officer: General Counsel | A-Award | 233,957 | $0.00 |
| Jun 18, 2026 | Cappello Joseph · officer: Chief Technical Officer | A-Award | 174,841 | $0.00 |
| Jun 18, 2026 | Tyree James L · director | A-Award | 28,409 | $0.00 |
| Jun 18, 2026 | Tyree James L · director | A-Award | 31,566 | $3.03 |
| Jun 18, 2026 | Zindrick Thomas · officer: President and CEO | A-Award | 730,601 | $0.00 |
| Jun 18, 2026 | Thomas John · director | A-Award | 28,409 | $0.00 |
| Jun 18, 2026 | Thomas John · director | A-Award | 31,566 | $3.03 |
| Jun 18, 2026 | Mirabelli Mary · director | A-Award | 28,409 | $0.00 |
| Jun 18, 2026 | Mirabelli Mary · director | A-Award | 31,566 | $3.03 |
| Jun 18, 2026 | Yu Yong · officer: Chief Scientific Officer | A-Award | 119,318 | $0.00 |
| Jun 18, 2026 | Smither John W · director | A-Award | 28,409 | $0.00 |
| Jun 4, 2026 | Smalling Ralph · officer: Head of Regulatory | Sale | 192 | $2.93 |
| Jun 2, 2026 | Thomas John · director | Sale | 10,000 | $2.98 |
| May 12, 2026 | Yu Yong · officer: Chief Scientific Officer | Sale | 605 | $2.97 |
| May 12, 2026 | Cappello Joseph · officer: Chief Technical Officer | Sale | 605 | $2.97 |
| May 12, 2026 | Zindrick Thomas · officer: President and CEO | Sale | 2,798 | $2.94 |
| May 12, 2026 | Smalling Ralph · officer: Head of Regulatory | Sale | 270 | $2.98 |
| Mar 26, 2026 | Zindrick Thomas · officer: President and CEO | Sale | 3,582 | $2.42 |
| Mar 26, 2026 | Smalling Ralph · officer: Head of Regulatory | Sale | 345 | $2.42 |
| Mar 26, 2026 | Smalling Ralph · officer: Head of Regulatory | Sale | 240 | $2.51 |
| Mar 26, 2026 | Yu Yong · officer: SVP, Clinical Development | Sale | 906 | $2.42 |
Institutional positioning
13F filings over the trailing two quarters
New 23Increased 36Reduced 31Sold out 11
| Filer | Action | Shares | Filed |
|---|---|---|---|
| WOODWARD DIVERSIFIED CAPITAL, LLC | Increased | 2,262,108 | Jul 28, 2026 |
| WOODWARD DIVERSIFIED CAPITAL, LLC | Increased | 2,117,183 | Apr 24, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 1,695,480 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Reduced | 1,677,724 | Aug 13, 2026 |
| Bleichroeder LP | Unchanged | 1,380,666 | Aug 13, 2026 |
| BLEICHROEDER LP | Increased | 1,380,666 | May 14, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 453,761 | May 15, 2026 |
| BlackRock, Inc. | Increased | 439,602 | Aug 7, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Reduced | 439,213 | Aug 12, 2026 |
| BLACKROCK, INC. | Increased | 405,872 | May 13, 2026 |
| CM Management, LLC | Increased | 400,000 | Aug 13, 2026 |
| BANK OF AMERICA CORP /DE/ | Increased | 328,803 | Aug 14, 2026 |
| BANK OF AMERICA CORP /DE/ | Reduced | 323,865 | May 18, 2026 |
| FLPUTNAM INVESTMENT MANAGEMENT CO | Reduced | 280,904 | May 5, 2026 |
| VANGUARD FIDUCIARY TRUST CO | New Position | 251,610 | May 8, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 2, 2026